Prominent examples include the determination of specific viruses as etiologic agents in specific cancers, the development of prophylactic vaccines to prevent these cancers, the initial identification and characterization of cellular oncoproteins and tumor suppressor proteins from studies of viral gene products, and the development of oncolytic virus-based cancer therapies. Here, TCHP is linked to cancer.